PDX model details
| PDX ID | a |
|---|---|
| Host Strain(and Source) | a Source: Monash University |
| Host Strain Immune system Humanized | YES |
| Host Type | None |
| Graft Site | None |
| Current Generation (* indicates number of generations grown in Castrate host) |
42 |
| Average PDX Generation Time (days +/- SEM) | 1234567890 |
| Tumour preparation | a |
| Tumour Characterization Technology | a |
| Tumour confirmed not to be of Mouse/EBV origin | a |
| Passage QA performed | a |
| Associated meta data | |
| PDX model availability | None |
| Governance restriction for distribution | |
| Pubmed ID | None |
| Markers | a |
|---|---|
| AR | None |
| PSA | Y |
| PSMA | None |
| NE | None |
| ERG | None |
No information in CNV Table
Clinical Information
| Sample Number | a |
|---|---|
| Sample Site | None |
| Sample source | None |
| Pathology Tumour Diagnosis | None |
| Gleason Score | None |
| Primary Gleason Score | None |
| Secondary Gleason Score | None |
| Tertiary Gleason Score | None |
| ISUP Grade Group | None |
| Tumour Grade | None |
| D'Amico Risk Classification | None |
| Tumour Volume (in cc) | None |
| Treatment Prior to Specimen Collection | None |
Patient Information
| Patient Number | a |
|---|---|
| Sex | a |
| Diagnosis | a |
| PSA at diagnosis (ng/mL) | a |
| Consent to share data | |
| Patient Tumour Collection (Current Model) | |
|---|---|
| Tumour sample ID | a |
| Patient Age (binned in 5 year age groups) | None |
No information in Mutation Table
No information in Gene expression
No information in Drug dosing Table